However, interest in GLP-1 drugs, particularly Ozempic, has also been fueled in part by social media discourse and ...

which is one of the registered products containing GLP-1 agonists from Novo Nordisk. According to the watchdog, Ozempic in ...

Ozempic microdosing is a new weight loss trend—but doctors are warning against it. Here's what to know, including benefits, ...

With Ozempic, your pen may contain four or eight doses ... A large review of studies compared GLP-1 agonist medications, including semaglutide, for lowering people’s risk of cardiovascular ...

These pose a health risk to the public. Sahpra cautions the public to not purchase and/or consume such products as their ...

Don't buy the Ozempic or Mounjaro you see online, warns SAHPRA, because you may be wasting your money or risking your health.

Patients taking Ozempic and other trendy injectables are going ... limitations in microdosing weight-loss medications, she ...

NurPhoto/Getty Images Microdosing GLP-1 weight loss drugs is a trend that ... So what we might do is prescribe the highest dose of Ozempic pen and teach people how to do low doses on it ...

“GLP-1 medications like Wegovy and Ozempic can absolutely be helpful tools ... The second possible reason is that the injector mechanism in the pen for Wegovy is different from the one used ...

Users of the blockbuster GLP-1 drugs may also adjust doses up or ... There’s very little difference in the sticker price between a pen with 2 mg of Ozempic and one with 8 mg.

But in March semaglutide (a GLP-1 receptor agonist sold as Ozempic for diabetes and Wegovy for weight-loss) was approved in America for cardiovascular disease in overweight people. In April ...